Role of Plasma Proteins in Pharmacokinetics of Micafungin, an Antifungal Antibiotic, in Analbuminemic Rats
Author(s) -
Fumie Abe,
Jun Ueyama,
Noriyo Kawasumi,
Masayuki Nadai,
Tamon Hayashi,
Miki Kato,
Masafumi Ohnishi,
Hiroko Saito,
Naoshi Takeyama,
Takaaki Hasegawa
Publication year - 2008
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00396-08
Subject(s) - micafungin , pharmacokinetics , multidrug resistance associated protein 2 , pharmacology , globulin , albumin , antibiotics , bioconcentration , echinocandins , blood proteins , antifungal , medicine , chemistry , biology , microbiology and biotechnology , biochemistry , amphotericin b , atp binding cassette transporter , transporter , bioaccumulation , organic chemistry , caspofungin , gene
There were no significant differences in the pharmacokinetics of micafungin and expression of hepatic multidrug resistance-associated protein 2 (ABCC2/Mrp2) between analbuminemic and Sprague-Dawley rats. Micafungin bound strongly to high-density lipoprotein (HDL) and moderately to gamma globulin. These results suggest that HDL and gamma globulin contribute to the pharmacokinetics of micafungin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom